Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Clinical trial of Sinovac's vaccine in RI still on track

  • News Desk


Bandung   /   Fri, November 13 2020   /  01:00 am
A nurse holds China's Sinovac vaccine, a potential vaccine for the coronavirus disease (COVID-19), at the Sao Lucas Hospital of the Pontifical Catholic University of Rio Grande do Sul (PUCRS), in Porto Alegre, Brazil August 8, 2020. (REUTERS/Diego Vara)

The team of Indonesian scientists conducting phase three clinical trials on a COVID-19 candidate vaccine developed by Chinese biopharmaceutical company Sinovac Biotech has said that the trials are still ongoing, despite the suspension of a similar trial in Brazil. Brazil’s National Health Surveillance Agency reported a serious adverse event (SAE) on Oct. 29 in a study participant involved in the phase three trial of the Sinovac vaccine, leading to a decision to suspend the trial in the country. Pauses in clinical trials are common and were also seen previously in the phase three trials for AstraZeneca’s and Johnson & Johnson’s candidate vaccines. In the latest development, Sinovac on Tuesday released a clarification of interruption in the phase three trial. “We have noticed some media reports. After communicating with the Brazilian partner, the Butant...